Detalles de la búsqueda
1.
A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
J Allergy Clin Immunol
; 145(1): 368-378.e13, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31194989
2.
Obligatory role of endoplasmic reticulum in brain FDG uptake.
Eur J Nucl Med Mol Imaging
; 46(5): 1184-1196, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617965
3.
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells.
Eur J Immunol
; 47(4): 743-753, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28198545
4.
The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis.
Carcinogenesis
; 34(3): 620-6, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23161574
5.
Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.
Cancer Med
; 11(1): 183-193, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796694
6.
Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report.
BMC Biotechnol
; 11: 104, 2011 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22074550
7.
Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins.
J Biol Chem
; 284(39): 26646-54, 2009 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19632988
8.
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha.
Int J Cancer
; 127(1): 101-10, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19877124
9.
Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor Efficiency.
Curr Med Chem
; 27(25): 4233-4248, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-30182839
10.
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection.
Cancers (Basel)
; 12(3)2020 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197460
11.
The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes.
Transl Oncol
; 13(5): 100752, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32302773
12.
A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B.
Int J Cancer
; 125(4): 751-8, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19479996
13.
L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.
Cancers (Basel)
; 11(9)2019 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31443604
14.
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
Front Immunol
; 9: 2905, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30619269
15.
A novel calix[4]pyrrole derivative as a potential anticancer agent that forms genotoxic adducts with DNA.
Sci Rep
; 8(1): 11075, 2018 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30038406
16.
Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.
Clin Cancer Res
; 12(8): 2575-82, 2006 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16638868
17.
Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.
Oncotarget
; 8(40): 67482-67496, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978047
18.
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Oncotarget
; 6(35): 37426-42, 2015 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460958
19.
Inflammation, DAMPs, tumor development, and progression: a vicious circle orchestrated by redox signaling.
Antioxid Redox Signal
; 20(7): 1086-97, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23373831
20.
Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine.
Cancer Med
; 2(4): 478-87, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24156020